Tuesday 06 May, 2025 02:48 PM
Site map | Locate Us | Login
   Polycab India spurts as Q4 PAT jumps 33% YoY to Rs 734 cr; declares dividend of Rs 35/sh    Volumes soar at CCL Products (India) Ltd counter    Safari Industries slips as Q4 PAT declines 13% YoY to Rs 38 crore    HUDCO board approves issuance of NCDs amounting to Rs 2,190 crore    Real Estate shares fall    Axis Bank Ltd down for fifth straight session    Bondada Engineering subsidiary receives purchase order from Bharti Airtel    Tata Steel Ltd spurts 1.78%, up for third straight session    Prataap Snacks records net loss of nearly Rs 12 crore in Q4 as input prices surge    Shilpa Medicare's Karnataka unit receives GMP approval from EMA    DCM Shriram jumps after Q4 PAT rises 52% YoY to Rs 179 cr    NSE SME Iware Supplychain Services slides on debut    Paras Defence inks MoU with Israel's HevenDrones to form JV for defence logistics drones    Bombay Dyeing & Manufacturing slides after Q4 PAT slumps 83% YoY to Rs 12 cr    Orient Bell Ltd leads gainers in 'B' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Senores Pharmaceuticals gains on acquiring Topiramate tablets from Wockhardt
06-May-25   10:51 Hrs IST

Shares of Wockhardt declined 2.15% to Rs 1,267 on the BSE.

The market size of Topiramate tablet in the USA was USD 111.47 million (MAT December 2024) as per IQVIA.

The acquisition will be funded through the initial public offer (IPO) proceeds raised by SPL. This is in line with the objects of the IPO stated in the red herring prospectus.

Senores Pharmaceuticals (Senores) is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms.

Wockhardt is a research based global pharmaceutical and Biotech Company.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40674856
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd